Beam Therapeutics
BEAM
BEAM
205 hedge funds and large institutions have $1.85B invested in Beam Therapeutics in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 77 increasing their positions, 58 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 30
15% less capital invested
Capital invested by funds: $2.18B → $1.85B (-$331M)
34% less call options, than puts
Call options by funds: $13.2M | Put options by funds: $20.1M
Holders
205
Holding in Top 10
3
Calls
$13.2M
Puts
$20.1M
Top Buyers
| 1 | +$37.2M | |
| 2 | +$34.3M | |
| 3 | +$11.6M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$11M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$8.09M |
Top Sellers
| 1 | -$11M | |
| 2 | -$5.16M | |
| 3 | -$4.85M | |
| 4 |
CAI
Capital Advisors Inc
Tulsa,
Oklahoma
|
-$4.24M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
-$3.72M |